Therapeutic Potential of Oligo-Fucoidan in Mitigating Peritoneal Dialysis-Associated Fibrosis
Peritoneal dialysis (PD) serves as a home-based kidney replacement therapy with increasing utilization across the globe. However, long-term use of high-glucose-based PD solution incites repeated peritoneal injury and inevitable peritoneal fibrosis, thus compromising treatment efficacy and resulting...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-11-01
|
| シリーズ: | Marine Drugs |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/1660-3397/22/12/529 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|